Te Tītoki Mataora and the Consortium for Medical Device Technologies (CMDT) invite submissions for the 2024 HealthTech Award for the Best Translational Research Project. This award recognises exceptional projects which have the potential to make a significant impact on a major healthcare problem, demonstrate innovation in concept, have potential for translation and/or commercialisation and are effectively communicated. 

This prestigious award is open nationally to applications from research projects that meet the guidelines for a RAP stage II project.

PRIZES INCLUDE

First place: $100,000

Second place: $80,000

Third place: $40,000

HOW TO ENTER

Submit an abstract

Abstracts using this template must be submitted to medtechresearchnetwork@auckland.ac.nz by Monday 31st May 2024. Abstracts may contain up to 200 words and 1x visual aid. Please read the judging criteria below carefully. 

Present at HealthTech Week 2024

The top abstracts will be shortlisted, and all teams will be notified of the outcomes by Friday 7th June 2024. These finalists will be required to present at the Te Tītoki Mataora Forum of HealthTech Week 2024 on Monday 24th June 2024*. Each finalist will have 5 minutes to present their work, plus 3 minutes for audience questions. The winner will be announced at the evening event on the same day. 

*Each HeathTech Award finalist team will receive 1x complimentary registration for the presenter to attend the Te Tītoki Mataora Forum Day 1, Monday 24th June 2024. 

Judging Criteria

• Clinical/end-user need: what is the unmet clinical problem/issue being addressed, its size and who are the clinical partners to translate the technology into clinical practice?
• Innovation: What is special about the technology? Is it disruptive and has proof of concept been achieved? Proof of concept achievement should be demonstrated using clinical/user data or other relevant information collected. 
• Commercial potential: IP position, understanding of the regulatory position, size of the market, competition and the advantage of the technology over current practice. Have hurdles to commercialisation been identified? If this is a project with a stronger public good outcome, what are the steps to scale up this technology to make it available to the community sustainably?
• Team and partnership: Who are the team members and partners (clinical, industry and engagement with Māori that will support the technology)?
• Future plans: How well thought out are the immediate next steps towards achieving success, e.g. scalability, business knowledge/plan and channels to market?